Mouthrinses as adjuncts in periodontal therapy.
Periodontal diseases are a group of related inflammatory disorders, initiated by dental plaque and causing destruction of the supporting structures of the teeth. Although the inflammatory response is a fundamental defence mechanism against bacterial infection, its persistence over a long period of time may extensively damage the periodontal tissues: cementum, alveolar bone, periodontal ligament and dentogingival tissues. These disorders, despite recent improvements in oral health are still a major cause of tooth loss in patients over 35 years of age.
Walsh
T F
TF
Department of Restorative Dentistry, University of Sheffield.
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000009:adverse effects / Q000627:therapeutic use*; D002594:Cetylpyridinium / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002710:Chlorhexidine / Q000627:therapeutic use; D002713:Chlorine / Q000627:therapeutic use; D003773:Dental Plaque / Q000188:drug therapy / Q000517:prevention & control; D004338:Drug Combinations; D005459:Fluorides / Q000627:therapeutic use; D005891:Gingivitis / Q000188:drug therapy; D006801:Humans; D007455:Iodine / Q000627:therapeutic use; D008875:Middle Aged; D009067:Mouthwashes / Q000009:adverse effects / Q000627:therapeutic use; D010087:Oxides / Q000627:therapeutic use; D010510:Periodontal Diseases / Q000188:drug therapy*; D011205:Povidone / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D013729:Terpenes / Q000627:therapeutic use; D014260:Triclosan / Q000627:therapeutic use
D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; D009067:Mouthwashes; D010087:Oxides; D012459:Salicylates; D013729:Terpenes; D014260:Triclosan; D002713:Chlorine; C057473:Listerine; D007455:Iodine; D002594:Cetylpyridinium; D011205:Povidone; D005459:Fluorides; D002710:Chlorhexidine